<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Nattel, Stanley</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Management of AF Based on New Science and New Guidelines</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-32</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses new research on atrial fibrillation (AF) and how it may contribute to disease management, the use of novel oral anticoagulants in periprocedural anticoagulation management, the clinical overlap between AF and heart failure, as well as an overview of new ACC/AHA/HRS guideline recommendations.</style></abstract><number><style face="normal" font="default" size="100%">52</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>